
Carmencita Belei
Examiner (ID: 5021, Phone: (571)272-2798 , Office: P/1678 )
| Most Active Art Unit | 1678 |
| Art Unit(s) | 1677, 1641, 1678 |
| Total Applications | 403 |
| Issued Applications | 162 |
| Pending Applications | 10 |
| Abandoned Applications | 231 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 11116377
[patent_doc_number] => 20160313350
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-10-27
[patent_title] => 'METHODS FOR DIAGNOSIS AND PROGNOSIS OF RENAL INJURY AND RENAL FAILURE USING TREFOIL FACTOR 3 FAILURE'
[patent_app_type] => utility
[patent_app_number] => 15/137982
[patent_app_country] => US
[patent_app_date] => 2016-04-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25095
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15137982
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/137982 | METHODS FOR DIAGNOSIS AND PROGNOSIS OF RENAL INJURY AND RENAL FAILURE USING TREFOIL FACTOR 3 FAILURE | Apr 24, 2016 | Abandoned |
Array
(
[id] => 12588900
[patent_doc_number] => 20180088129
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-03-29
[patent_title] => Immunoassay for Collagen Type VI Sequence
[patent_app_type] => utility
[patent_app_number] => 15/563607
[patent_app_country] => US
[patent_app_date] => 2016-03-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12882
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15563607
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/563607 | Immunoassay for Collagen Type VI Sequence | Mar 30, 2016 | Abandoned |
Array
(
[id] => 12644886
[patent_doc_number] => 20180106793
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-04-19
[patent_title] => REAGENT AND METHOD FOR ASSAYING THROMBIN-ANTITHROMBIN COMPLEX
[patent_app_type] => utility
[patent_app_number] => 15/562839
[patent_app_country] => US
[patent_app_date] => 2016-03-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9536
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -5
[patent_words_short_claim] => 70
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15562839
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/562839 | REAGENT AND METHOD FOR ASSAYING THROMBIN-ANTITHROMBIN COMPLEX | Mar 28, 2016 | Abandoned |
Array
(
[id] => 11016747
[patent_doc_number] => 20160213700
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-07-28
[patent_title] => 'TREATMENT OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD)'
[patent_app_type] => utility
[patent_app_number] => 15/081073
[patent_app_country] => US
[patent_app_date] => 2016-03-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 17352
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15081073
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/081073 | Treatment of chronic obstructive pulmonary disease (COPD) | Mar 24, 2016 | Issued |
Array
(
[id] => 13290779
[patent_doc_number] => 10156576
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-12-18
[patent_title] => Method for enrichment and separation of spinal fluid glycoprotein, method for searching for marker for central nervous system diseases which utilizes the aforementioned method, and marker for central nervous system diseases
[patent_app_type] => utility
[patent_app_number] => 15/071419
[patent_app_country] => US
[patent_app_date] => 2016-03-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 17598
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 264
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15071419
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/071419 | Method for enrichment and separation of spinal fluid glycoprotein, method for searching for marker for central nervous system diseases which utilizes the aforementioned method, and marker for central nervous system diseases | Mar 15, 2016 | Issued |
Array
(
[id] => 12329604
[patent_doc_number] => 09945858
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-04-17
[patent_title] => Compositions and methods for detecting and quantifying host cells protein in cell lines and recombinant polypeptide products
[patent_app_type] => utility
[patent_app_number] => 15/065615
[patent_app_country] => US
[patent_app_date] => 2016-03-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 28
[patent_no_of_words] => 26845
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 193
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15065615
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/065615 | Compositions and methods for detecting and quantifying host cells protein in cell lines and recombinant polypeptide products | Mar 8, 2016 | Issued |
Array
(
[id] => 16063479
[patent_doc_number] => 10690681
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-06-23
[patent_title] => Methods to detect myocardial injury and uses thereof
[patent_app_type] => utility
[patent_app_number] => 15/062759
[patent_app_country] => US
[patent_app_date] => 2016-03-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 10843
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 271
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15062759
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/062759 | Methods to detect myocardial injury and uses thereof | Mar 6, 2016 | Issued |
Array
(
[id] => 17743682
[patent_doc_number] => 11391742
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-07-19
[patent_title] => Free histone proteins as biomarkers
[patent_app_type] => utility
[patent_app_number] => 15/549495
[patent_app_country] => US
[patent_app_date] => 2016-02-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 18869
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 293
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15549495
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/549495 | Free histone proteins as biomarkers | Feb 8, 2016 | Issued |
Array
(
[id] => 12179937
[patent_doc_number] => 20180038873
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-02-08
[patent_title] => 'USE OF NHE3 AS A BIOMARKER FOR RADIATION BIODOSIMETRY'
[patent_app_type] => utility
[patent_app_number] => 15/549166
[patent_app_country] => US
[patent_app_date] => 2016-02-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5168
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15549166
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/549166 | USE OF NHE3 AS A BIOMARKER FOR RADIATION BIODOSIMETRY | Feb 4, 2016 | Abandoned |
Array
(
[id] => 12127529
[patent_doc_number] => 20180011115
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-01-11
[patent_title] => 'DIAGNOSIS OF RISK OF UROTHELIAL CANCER'
[patent_app_type] => utility
[patent_app_number] => 15/547608
[patent_app_country] => US
[patent_app_date] => 2016-01-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 6576
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15547608
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/547608 | DIAGNOSIS OF RISK OF UROTHELIAL CANCER | Jan 28, 2016 | Abandoned |
Array
(
[id] => 12152878
[patent_doc_number] => 20180024142
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-01-25
[patent_title] => 'IMMUNOASSAYS FOR HIGH POSITIVELY CHARGED PROTEINS'
[patent_app_type] => utility
[patent_app_number] => 15/547080
[patent_app_country] => US
[patent_app_date] => 2016-01-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 16591
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15547080
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/547080 | IMMUNOASSAYS FOR HIGH POSITIVELY CHARGED PROTEINS | Jan 27, 2016 | Abandoned |
Array
(
[id] => 12139484
[patent_doc_number] => 20180017567
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-01-18
[patent_title] => 'QUANTITATIVE ASSAY FOR HEAT SHOCK PROTEINS 70 (HSP70) PROTEIN IN BODY FLUIDS'
[patent_app_type] => utility
[patent_app_number] => 15/546394
[patent_app_country] => US
[patent_app_date] => 2016-01-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 17565
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15546394
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/546394 | Quantitative assay for heat shock proteins 70 (Hsp70) protein in body fluids | Jan 26, 2016 | Issued |
Array
(
[id] => 10800679
[patent_doc_number] => 20160146836
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-05-26
[patent_title] => 'USE OF ALPHA-CRYSTALLIN B (CRYAB) IN THE ASSESSMENT OF HEART FAILURE'
[patent_app_type] => utility
[patent_app_number] => 15/007840
[patent_app_country] => US
[patent_app_date] => 2016-01-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 18244
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15007840
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/007840 | USE OF ALPHA-CRYSTALLIN B (CRYAB) IN THE ASSESSMENT OF HEART FAILURE | Jan 26, 2016 | Abandoned |
Array
(
[id] => 14796745
[patent_doc_number] => 10401371
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-09-03
[patent_title] => Method of measuring cholesterol levels by using immunogenic method
[patent_app_type] => utility
[patent_app_number] => 15/545656
[patent_app_country] => US
[patent_app_date] => 2016-01-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 8751
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 46
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15545656
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/545656 | Method of measuring cholesterol levels by using immunogenic method | Jan 21, 2016 | Issued |
Array
(
[id] => 12152885
[patent_doc_number] => 20180024149
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-01-25
[patent_title] => 'PREDICTIVE MARKERS OF IBD'
[patent_app_type] => utility
[patent_app_number] => 15/544158
[patent_app_country] => US
[patent_app_date] => 2016-01-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 8080
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15544158
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/544158 | PREDICTIVE MARKERS OF IBD | Jan 21, 2016 | Abandoned |
Array
(
[id] => 12120115
[patent_doc_number] => 20180003701
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-01-04
[patent_title] => 'IMMUNOGLOBULIN ASSAYS USING NANOPARTICLES'
[patent_app_type] => utility
[patent_app_number] => 15/545674
[patent_app_country] => US
[patent_app_date] => 2016-01-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 8307
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15545674
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/545674 | IMMUNOGLOBULIN ASSAYS USING NANOPARTICLES | Jan 20, 2016 | Abandoned |
Array
(
[id] => 12139493
[patent_doc_number] => 20180017576
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-01-18
[patent_title] => 'COMPOUNDS AND METHODS FOR THE DETECTION OF CALPROTECTIN'
[patent_app_type] => utility
[patent_app_number] => 15/544938
[patent_app_country] => US
[patent_app_date] => 2016-01-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 10327
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15544938
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/544938 | COMPOUNDS AND METHODS FOR THE DETECTION OF CALPROTECTIN | Jan 20, 2016 | Abandoned |
Array
(
[id] => 12120114
[patent_doc_number] => 20180003700
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-01-04
[patent_title] => 'METHOD FOR THE FORMATION AND USE OF AN IMMUNOLABELING COMPLEX'
[patent_app_type] => utility
[patent_app_number] => 15/538691
[patent_app_country] => US
[patent_app_date] => 2016-01-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 5831
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15538691
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/538691 | METHOD FOR THE FORMATION AND USE OF AN IMMUNOLABELING COMPLEX | Jan 18, 2016 | Abandoned |
Array
(
[id] => 18997125
[patent_doc_number] => 11913961
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-02-27
[patent_title] => Method for preparing a biological sample for use in an immunolabeling process
[patent_app_type] => utility
[patent_app_number] => 15/543465
[patent_app_country] => US
[patent_app_date] => 2016-01-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 4321
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 174
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15543465
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/543465 | Method for preparing a biological sample for use in an immunolabeling process | Jan 17, 2016 | Issued |
Array
(
[id] => 10807825
[patent_doc_number] => 20160153983
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-06-02
[patent_title] => 'BIOMARKERS, METHODS AND KITS FOR THE DIAGNOSIS OF RHEUMATOID ARTHRITIS'
[patent_app_type] => utility
[patent_app_number] => 14/993883
[patent_app_country] => US
[patent_app_date] => 2016-01-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 14390
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14993883
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/993883 | BIOMARKERS, METHODS AND KITS FOR THE DIAGNOSIS OF RHEUMATOID ARTHRITIS | Jan 11, 2016 | Abandoned |